Cargando…
A new method for the high-precision assessment of tumor changes in response to treatment
MOTIVATION: Imaging demonstrates that preclinical and human tumors are heterogeneous, i.e. a single tumor can exhibit multiple regions that behave differently during both development and also in response to treatment. The large variations observed in control group, tumors can obscure detection of si...
Autores principales: | Tar, P D, Thacker, N A, Babur, M, Watson, Y, Cheung, S, Little, R A, Gieling, R G, Williams, K J, O’Connor, J P B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061877/ https://www.ncbi.nlm.nih.gov/pubmed/29547950 http://dx.doi.org/10.1093/bioinformatics/bty115 |
Ejemplares similares
-
Habitat Imaging of Tumors Enables High Confidence Sub-Regional Assessment of Response to Therapy
por: Tar, Paul David, et al.
Publicado: (2022) -
Data‐driven mapping of hypoxia‐related tumor heterogeneity using DCE‐MRI and OE‐MRI
por: Featherstone, Adam K., et al.
Publicado: (2017) -
A reformulation of pLSA for uncertainty estimation and hypothesis testing in bio-imaging
por: Tar, P D, et al.
Publicado: (2020) -
Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers
por: Williams, Kaye J., et al.
Publicado: (2019) -
Oxygen-enhanced MRI can accurately identify, quantify and map tumour hypoxia in preclinical models
por: O'Connor, JPB, et al.
Publicado: (2015)